Skip to content

Intensive long-term rehabilitation for people living with chronic spinal cord injury: a feasibility trial

Intensive long-term rehabilitation for people living with chronic spinal cord injury: a feasibility trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12621000679886
Acronym
SIP Rehab (Spinal Injury Project, Rehab)
Enrollment
5
Registered
2021-06-03
Start date
2021-09-23
Completion date
2021-09-23
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study will measure whether an intensive, long-term rehabilitation program can be delivered safely and effectively to people living with chronic spinal cord injury in Australia. It will also measure whether long-term intensive rehabilitation improves overall health, social outcomes and functional recovery for people living with chronic spinal cord injury.

Interventions

The SIP Rehab study is a feasibility trial using an uncontrolled pre-post design, which measures feasibility and performance before and after the intensive long-term rehabilitation intervention. This trial aims to examine whether long-term intensive rehabilitation therapy can be safely and effectively delivered to people living with chronic spinal cord injury in Australia. The feasibility trial will also test whether long-term intensive rehabilitation improves overall health, social outcomes and

The SIP Rehab study is a feasibility trial using an uncontrolled pre-post design, which measures feasibility and performance before and after the intensive long-term rehabilitation intervention. This trial aims to examine whether long-term intensive rehabilitation therapy can be safely and effectively delivered to people living with chronic spinal cord injury in Australia. The feasibility trial will also test whether long-term intensive rehabilitation improves overall health, social outcomes and functional recovery for people living with chronic spinal cord injury. This feasibility trial is a necessary first step toward the anticipated full cell transplantation – rehabilitation clinical trial that the Clem Jones Centre for Neurobiology and Stem Cell Research at Griffith University is working towards. The ‘on-site’ program (16 weeks) used in the trial will include: 2 hours per day on site, 5 days per week, with an additional 5x 30 minutes of functional electrical stimulation sessions. The location for the ‘on-site’ portion of the intervention is at a specialised gym: “Making Strides” on the Gold Coast, Queensland. The total weekly ‘on-site’ activities will consist of: • Standing: 150 min per week (30 min per day, 5 days per week) • Gait training: 90 min per week (30 min per day, 3 days per week) • Upper limb strength: 150 min per week (30 min per day, 5 days per week) • Trunk stability/core strength: 90 min per week (30 min per day, 3 days per week) • Aerobic training: 120 min per week (30 min per day, 4 days per week) • Functional electrical stimulation (FES): 150 min per week (30 min per day, 5 days per week) The ‘at-home’ program (10 weeks), will include a personalised program involving the following exercises: • Unilateral humeral abduction • Unilateral humeral flexion • Unilateral dumbbell shoulder press • Bilateral dumbbell chest press • Dumbbell assisted sit-up • Short sitting unilateral band row • Plank • Palof press • Dumbbell assisted back extension performed in wheelchair. Each exercise is to be performed at weights prescribed by the Exercise Physiologist. Each exercise is to be performed for 3 sets of 15 reps. The programs, including intensity levels for each participant, will be personalised by qualified exercise physiologists at the service provider (Making Strides) to suit each individual’s injury as it is difficult to have a standardised program due to the varied nature of SCI, the variance in function, and the exercise capacity. For the ‘on site’ portion of the trial, materials will include: bodyweight support supplied via harness and overhead hoist, rubber resistance bands, 20m track system, squat rack with fixed arm supports, forearm support walking frames, crutches, hand cycle ergometer, adaptive ski ergometer, cable machines, arm cycle ergometry, seated ski ergometry, ropes, functional electrical stimulation, and weights. The ‘at home’ portion of the trial will use weights and rubber resistance bands (supplied). The 'at home' program will be personalised as it is difficult to have a standardised program due to the nature of SCI, the variance in function, and the exercise capacity. For participant safety and reproducibility, as well as to minimise assistance and equipment needs, the exercises listed below will be prescribed to each participant to be performed 5 days each week. Each exercise is to be performed for 3 sets of 15 reps. The mode of delivery will be face-to-face for the ‘on-site’ portion of the trial, and the ‘at-home’ program will be prescribed by the exercise physiologist and will be performed at home, or at a local gym, with weekly 30-minute virtual check ins with exercise physiologists. The 'on-site' program will be completed before the 'at-home' program and the 'at-home' program will begin after the 'on-site' program has been completed. i.e. the programs will be run sequentially. The order of the programs is the same for all participants. Intervention adherence or fidelity will be assessed through the use of a log of activity, recorded by the participant during the whole program, and by the staff at Making Strides during the on-site program. Adherence and Fidelity will be analysed by an independent statistical team. Strategies to maintain or improve fidelity, will be via support of Making Strides staff to motivate and maintain fidelity of participation. For the ‘at-home’ program, Making Strides staff will perform a weekly virtual call with the participant. The total intervention time is 26 weeks (16 weeks 'on site' and 10 weeks 'at home') then there is a follow up with participants at 2 weeks post intervention and 8 weeks post intervention.

Sponsors

Griffith University
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion/exclusion criteria for participants have been determined in consultation with medical and rehabilitation specialists including a clinician with a lived experience of SCI. Participants are eligible to be included in the study only if all the following criteria apply: i. Have sustained a traumatic spinal cord injury a minimum of 12 months prior to consent and have completed their primary rehabilitation; ii. Have stable neurological level and functional ability of more than 6 months in duration; iii. Are over 18 years and able to give informed consent; iv. Are ASIA A or B (as per the International Standards for Neurological Classification of SCI); v. Are able and willing to attend an exercise program five times per week for 26 (16 weeks 'on-site' and 10 weeks 'at-home') weeks; vi. Are considered by their general practitioner or specialist medical consultant to be fit to undertake the exercise program (documented approval by general practitioner or specialist medical consultant required).

Exclusion criteria

Participants are excluded from the study if any of the following criteria apply: i. Have significant concomitant central nervous system, peripheral nervous system or musculoskeletal system injuries or disorders limiting ability to exercise; ii. Have had recent major trauma or surgery within the last 6 months; iii. Have an existing stage 3 or 4 pressure ulcer according to the National Pressure Ulcer Advisory Panel classification; iv. Have endocrinopathy or metabolic disorders of the bone, such as Paget’s disease, lytic or renal bone disease, and senile osteoporosis; v. Have a medical history of exposure to medication(s) known to affect mineral or bone metabolism; vi. Have significant impairment or disability, including physical, neurological or psychological impairments, additional to the spinal cord injury; vii. Have a history of long bone fracture incompletely healed; viii. Have extensive fixed contractures in the upper or lower limbs; ix. Have severe spasticity; x. Have uncontrolled neuropathic pain; xi. Have autonomic dysreflexia without a management plan; xii. Are unable to attend the 2-week pre-assessment and the 8-week follow-up assessments; xiii. Have any contraindications to FES such as a cardiac pacemaker, epilepsy, lower limb fracture or pregnancy; xiv. Have any other serious medical condition including malignancies, psychiatric, behavioral or drug dependency problems, which are likely to influence the participant’s ability to cooperate or in the opinion of the study investigator would prevent adherence to the protocol; xv. Have symptomatic, radiologically demonstrated, or provocatively demonstrated ischaemic heart disease; xvi. Have current thromboembolic disease; xvii. Are using illicit drugs; xviii. Are participating in other clinical trials (including medication, therapeutic interventions and alternative therapies) or taking medications (including herbal preparations) that are not considered to be standard care as per the protocol; xix. Are unable to tolerate expected exercise load.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026